MAPK14 — Mitogen-Activated Protein Kinase 14 (p38α)

MAPK14 — Mitogen-Activated Protein Kinase 14 (p38α)

Overview

MAPK14 (Mitogen-Activated Protein Kinase 14), also known as p38α or CSBP (CSAID-binding protein), is a serine/threonine kinase belonging to the MAPK family. As one of four p38 MAPK isoforms (α, β, γ, δ), p38α is the most widely expressed and studied, with critical roles in cellular stress responses, inflammation, and neuronal function. The gene is located on chromosome 6p21.3 and encodes a 360-amino acid protein that is activated by cellular stress, inflammatory cytokines, and growth factors. MAPK14 is catalogued as NCBI Gene ID [5600](https://www.ncbi.nlm.nih.gov/gene/5600) and OMIM [600289](https://omim.org/entry/600289).

MAPK14 — Mitogen-Activated Protein Kinase 14 (p38α)

Overview

MAPK14 (Mitogen-Activated Protein Kinase 14), also known as p38α or CSBP (CSAID-binding protein), is a serine/threonine kinase belonging to the MAPK family. As one of four p38 MAPK isoforms (α, β, γ, δ), p38α is the most widely expressed and studied, with critical roles in cellular stress responses, inflammation, and neuronal function. The gene is located on chromosome 6p21.3 and encodes a 360-amino acid protein that is activated by cellular stress, inflammatory cytokines, and growth factors. MAPK14 is catalogued as NCBI Gene ID [5600](https://www.ncbi.nlm.nih.gov/gene/5600) and OMIM [600289](https://omim.org/entry/600289).

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">p38α Mitogen-Activated Protein Kinase</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MAPK14</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>p38α, CSBP, RK, SAPK2A</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitogen-Activated Protein Kinase 14</td></tr>
<tr><td><strong>Chromosome</strong></td><td>6p21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[5600](https://www.ncbi.nlm.nih.gov/gene/5600)</td></tr>
<tr><td><strong>OMIM</strong></td><td>600289</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000166401</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q16539](https://www.uniprot.org/uniprot/Q16539)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis</td></tr>
</table>
</div>

Molecular Function

Protein Structure

MAPK14 is a serine/threonine kinase with a characteristic kinase domain that undergoes dual phosphorylation at Thr180 and Tyr182 for activation. The protein contains:

The active form requires both Thr180 and Tyr182 phosphorylation by upstream MAP kinase kinases (MKK3, MKK4, and MKK6).

Activation Mechanisms

MAPK14 is activated by diverse stimuli:

Cellular Stress:

• Oxidative stress (ROS, H2O2)
• UV radiation
• Osmotic stress
• Ischemia/hypoxia

• TNF-α, IL-1β, IL-6
• TGF-β
• Interferons

• BDNF
• NGF
• EGF

Signal Transduction

The canonical MAPK14 cascade:
Cellular stress/inflammatory signals
↓
MKK3/MKK6 (MAP2K)
↓
MAPK14 (p38α) [Thr180/Tyr182 phosphorylation]
↓
Downstream substrates (transcription factors, kinases, cytoskeletal proteins)
↓
Cellular responses (inflammation, apoptosis, differentiation)

Role in Alzheimer's Disease

Neuroinflammation

MAPK14 is a central driver of neuroinflammation in AD:

Microglial Activation:

• p38 MAPK is rapidly activated in microglia surrounding amyloid plaques
• Drives production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)
• Promotes cyclooxygenase-2 (COX-2) and iNOS expression
• Creates chronic inflammatory microenvironment

• TNF-α and IL-1β further activate p38 in neighboring cells
• Amplifies neuroinflammation in a feed-forward manner
• Leads to progressive neuronal dysfunction

• p38 inhibition reduces microglial activation
• Decreases pro-inflammatory cytokine production
• Attenuates synaptic dysfunction in AD models

Amyloid-Beta Metabolism

MAPK14 directly influences amyloid-beta metabolism:

APP Processing:

• p38 MAPK regulates β-secretase (BACE1) expression
• Affects γ-secretase activity indirectly
• Impacts amyloid precursor protein (APP) trafficking

• p38 activation mediates Aβ-induced neuronal death
• Regulates Aβ-induced oxidative stress
• Controls inflammatory response to Aβ

• p38 inhibitors reduce amyloid burden in animal models
• May enhance Aβ clearance mechanisms

Tau Pathology

MAPK14 contributes to tau pathology through multiple mechanisms:

Direct Phosphorylation:

• p38α can phosphorylate tau at multiple sites

• Promotes NFT formation

• Activates other tau kinases (GSK-3β, CDK5)
• Creates synergistic phosphorylation pattern

• Dual targeting of p38 and tau kinases may be beneficial

Synaptic Dysfunction

p38 MAPK mediates Aβ-induced synaptic impairment:

• Reduces synaptic plasticity markers
• Impairs LTP (long-term potentiation)
• Contributes to memory deficits
• Affects AMPA receptor trafficking

Role in Parkinson's Disease

Neuroinflammation

In PD, MAPK14 drives neuroinflammation in the substantia nigra:

• Activated microglia express elevated p38
• Contributes to dopaminergic neuron death
• Cytokine-mediated toxicity amplifies pathology

Alpha-Synuclein Pathology

p38 MAPK affects α-synuclein:

• Regulates α-synuclein phosphorylation at Ser129
• Influences aggregation propensity
• Controls inflammatory response to α-synuclein aggregates

Mitochondrial Dysfunction

p38 contributes to mitochondrial impairment in PD:

• Mediates toxin-induced mitochondrial damage
• Regulates apoptotic pathways
• Contributes to energy failure

Therapeutic Potential

p38 inhibitors show promise in PD models:

• Reduce microglial activation
• Protect dopaminergic neurons
• Improve behavioral outcomes

Role in Neuroinflammation

Microglial Signaling

MAPK14 is central to microglial inflammatory responses:

Activation Cascade:

Cytokine Production:

• TNF-α, IL-1β, IL-6, IL-12
• Chemokines (MCP-1, MIP-1α)
• Prostaglandins via COX-2

Astrocyte Function

p38 MAPK regulates astrocyte responses:

• Controls inflammatory mediator release
• Affects astrocyte reactivity
• Modulates metabolic support to neurons

Neuronal Vulnerability

p38 activation in neurons triggers:

• Apoptotic pathways
• Oxidative stress
• Excitotoxicity
• Calcium dysregulation

Signaling Pathways

Upstream Regulators

MAPK14 is activated by:

MAP2Ks:

• MKK3 (specific for p38)
• MKK4 (also activates JNK)
• MKK6 (specific for p38)

• TAK1
• MLK3
• MEKK1-4

Downstream Effectors

p38 MAPK phosphorylates numerous substrates:

Transcription Factors:

• ATF2, c-Fos, c-Jun
• CREB, MEF2
• p53, NF-κB

• MSK1/2, MNK1/2
• PRAK (MAPKAPK3)
• MK2 (MAPKAPK2)

• Tau, MAPs
• Actin regulators

Therapeutic Implications

p38 Inhibitors

Several p38 MAPK inhibitors have been developed:

Clinical Candidates:

• Losmapimod (GW856553)
• PH-797804
• VX-745, VX-702

• CNS penetration limited
• Peripheral side effects
• Limited efficacy in chronic diseases

• Brain-penetrant inhibitors needed
• Disease-modifying potential
• Combination approaches

Biomarker Potential

p38 activation markers:

• Phospho-p38 in CSF
• Downstream cytokines (IL-1β, TNF-α)
• Microglial activation imaging

Expression Patterns

Brain Distribution

MAPK14 is expressed in:

• Neurons (high in hippocampus, cortex)
• Microglia (constitutively low, activation-induced)
• [Astrocytes](/cell-types/astrocytes) Oligodendrocytes

Cellular Localization

• Cytoplasmic (inactive)
• Nuclear (active, after stimulation)
• Mitochondrial (in stress responses)

Regulation

p38 activity is controlled by:

• Phosphorylation (activation/inactivation)
• Phosphatases (PP2C, MKP)
• Scaffold proteins
• Subcellular localization

Disease Associations

| Disease | Role | Evidence |
|---------|------|----------|
| Alzheimer's Disease | Neuroinflammation, tau phosphorylation, Aβ toxicity | Strong |
| Parkinson's Disease | Neuroinflammation, α-syn pathology | Moderate-Strong |
| Multiple Sclerosis | Demyelination, inflammation | Strong |
| Amyotrophic Lateral Sclerosis | Motor neuron inflammation | Moderate |
| Stroke | Ischemic injury, inflammation | Strong |

Key Publications

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/5600](https://www.ncbi.nlm.nih.gov/gene/5600)
• Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166401](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166401)
• OMIM: [https://omim.org/entry/600289](https://omim.org/entry/600289)
• UniProt: [https://www.uniprot.org/uniprot/Q16539](https://www.uniprot.org/uniprot/Q16539)

See Also

• [MAPK Signaling Pathway](/mechanisms/mapk-signaling-pathway) — Core pathway involving MAPK14
• [Neuroinflammation](/mechanisms/neuroinflammation) — Central role in neuroinflammation
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
• [Parkinson's Disease](/diseases/parkinsons-disease) — Primary disease association
• [Tau Pathology](/mechanisms/tau-pathology) — Role in tau phosphorylation
• [Amyloid-Beta](/proteins/amyloid-beta) — Aβ metabolism connection

References

Pathway Diagram

Pathway Diagram

The following diagram shows the key molecular relationships involving MAPK14 — Mitogen-Activated Protein Kinase 14 (p38α) discovered through SciDEX knowledge graph analysis: